Recent Advances in the Biology of BDNF And the Newly Identified Pro-Peptide

Toshiyuki Mizui1, 2*, Masami Kojima1,2,3#

Biomedical Research Inst. (BMD), National Institute of Advanced Industrial Science and Technology (AIST), 1-8-31 Midorioka, Ikeda, Osaka, 563-8577 Japan

Core Research for Evolutional Science and Technology (CREST), Science and Technology Agency (JST), Kawaguchi, 332-0012, Japan

Graduate School of Frontier Bioscience, Osaka University, Suita 565-0871, Japan

Most growth factors are initially synthesized as precursors. To produce biologically active mature peptides, the pro-domain is cleaved by proteolytic processing. However, compared with mature bioactive growth factors, the biological roles of pro-domains are poorly understood. Recent new findings on brain-derived neurotrophic factor (BDNF), a growth factor in the brain that promotes neuronal survival, differentiation, and synaptic plasticity, have been reported. Interestingly, the pro-domain (pro-peptide) of BDNF is endogenously present and localized at presynaptic termini, where it surprisingly functions as a facilitator of long-term depression (LTD). Given that BDNF elicits synaptic transmission and long-term potentiation (LTP), BDNF and its pro-peptide might exert distinct roles in synaptic plasticity in the central nervous system (CNS). In addition to reports on the BDNF pro-peptide, we review recent literature on the role of BDNF in the peripheral nervous system (PNS), and in brain-body interactions following exercise. Together, these findings provide new insight into BDNF biology.

Neurotrophins (NTs), including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4), exert distinct biological actions by binding to their cognate tyrosine kinase receptors (NGF to TrkA, BDNF and NT-4 to TrkB, and NT-3 to TrkC), as well as to the low-affinity neurotrophin receptor p75NTR, which belongs to the tumor necrosis factor (TNF) family1-3. The discovery of NTs and their receptor components has provided new insight into the role of NTs in the formation of neuronal networks during nervous system development and synaptic plasticity, memory formation, learning, and memory in the adult brain1,3-5. Furthermore, specific neuronal populations require one or more NTs that act spatially and temporally1,3,6. For synaptic plasticity, NTs exert long- and short-term actions; long-term trophic actions depend on gene regulation, whereas short-term effects, including chemotrophic effects on developing neurons and synaptic events, are controlled by NT-mediated activation of intracellular effectors5,7. Since most of the existing literature focuses on the signaling mechanisms and transcriptional/translational control of NTs, we herein concentrate on post-translational aspects, in particular the effects of BDNF and its pro-domain (or pro-peptide) on synaptic plasticity in the brain.

Like other growth factors, BDNF is initially synthesized as a precursor composed of 270 amino acid residues. The pre-pro-protein includes a signal sequence, a pro-domain, and a mature domain. To produce the mature form of BDNF, the N-terminal 120 amino acid pro-domain is cleaved by intracellular and/or extracellular proteases such as furin, pro-hormone convertase, and plasmin in the trans-Golgi and secretory granules, releasing BDNF8. The intracellular mechanisms of BDNF processing have been covered in several reports9,10. In neurons, the N-terminal pro-domain of precursor BDNF is cleaved in trans-Golgi and secretory granules, and BDNF is secreted through constitutive and/or neuronal activity-regulated secretion pathways in a neuronal activity- and Ca2+-dependent manner (reviewed by Lessmann and Brigadski8). Thus, the activity-dependent secretion of BDNF is required for BDNF-dependent regulation of synaptic transmission and long-term synaptic plasticity5. The roles of BDNF on synapses are described below.

BDNF mRNAs are highly expressed in the brain, particularly in the hippocampus and cortex11. Expression of BDNF is controlled by neuronal activity and excitatory transmission5. Importantly, Dieni et al. (2012) demonstrated that BDNF is present in large, dense core vesicles within the excitatory presynaptic termini in the adult mouse hippocampus12, implicating BDNF in synaptic transmission and plasticity, as subsequently proven by several groups. In cultured neurons, acute application of exogenous BDNF increased neuronal activity and synaptic transmission13, and application of exogenous BDNF induced LTP in neonatal hippocampal slices14. Treatment with tropomyosin receptor kinase B (TrkB)-IgG, a fusion protein that scavenges endogenous BDNF, inhibited LTP in adult hippocampal slices14, and recombinant BDNF rescued defective basal synaptic transmission and hippocampal LTP in BDNF knockout mice15. Furthermore, BDNF acts through TrkB, presynaptically but not postsynaptically, to modulate LTP16. Inhibition of p75NTR does not block BDNF regulation of presynaptic function and LTP in the hippocampus16, and more importantly, mutation of TrkB receptor at the Phospholipase C (PLC)-γ docking site, but not at the SH2-containing collagen-related proteins (Shc) docking site, impaired hippocampal LTP17, demonstrating the importance of TrkB-PLC-γ docking in BDNF-dependent LTP in the hippocampus.

It is reported that BDNF controls numerous biological processes in the nervous system1,3,5. Thus, a thorough understanding of the role of the pro-domain could expand our appreciation of BDNF biology.

A previous report showed that the BDNF pro-peptide/pro-domain acts as a molecular chaperone to assist the folding of BDNF18. We previously reported that a single-nucleotide polymorphism (SNP) that changes a valine to a methionine at codon 66 (Val66Met) in the pro-region of human BDNF affects memory function as well as the secretion of BDNF19. These results suggest that the BDNF pro-peptide may influence the biological actions of BDNF. To understand the functions of the BDNF pro-peptide, it is important to investigate and clarify the presence and localization of endogenous BDNF. Recently, Dieni et al. (2012) performed immunocytochemical and electron microscopy studies, and demonstrated that BDNF and its pro-peptide are both localized in dense core vesicles in excitatory presynaptic termini in the adult mouse hippocampus12. Notably, this report suggested an anterograde mode of action of BDNF in the central nervous system (CNS), distinct from the retrograde model derived from experiments with NGF in the peripheral nervous system (PNS). The authors further determined the amount of BDNF, precursor BDNF, and its pro-peptide, and showed that BDNF and its pro-peptide were approximately 10-fold more abundant than precursor BDNF in the adult mouse brain.

The BDNF pro-peptide, a portion of proBDNF, can enhance hippocampal LTD6. To induce LTD, low-frequency stimulation (LFS; 1 Hz, 900 pulses, 15 min) was applied to Schaffer collaterals of hippocampal slices prepared from 3- to 4-week-old mice, and field excitatory postsynaptic potential (fEPSP) slopes were recorded in the CA1 area. A 30 min treatment with the BDNF pro-peptide enhanced LTD without affecting basal transmission, and sub-nanomolar concentrations of the BDNF pro-peptide were sufficient for synapse facilitation. Importantly, application of the BDNF pro-peptide to Bdnf-/- hippocampal slices facilitated LTD, confirming that the BDNF pro-peptide acts independently of an interaction with endogenous BDNF. BDNF pro-peptide-dependent facilitation of hippocampal LTD requires activation of the p75NTR receptor and GluN2B/N-methyl-D-aspartate (NMDA) receptor subunit 2B-containing receptors. Moreover, the BDNF pro-peptide activates NMDA-induced ?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor endocytosis, a critical mechanism for LTD expression. Together, these findings show that the BDNF pro-peptide stimulates synaptic plasticity, particularly LTD, and regulates a critical mechanism for promoting synaptic depression.

Comparison of the properties of BDNF and its pro-peptide indicated potential mechanistic and biological interactions. BDNF and its pro-peptide are basic and acidic, respectively, with isoelectric points of 9.6 and 5.220, which suggests that they may bind in an electrostatic manner. We sought to investigate this putative interaction using surface plasmon resonance and biochemical methods20. Surprisingly, the BDNF pro-peptide binds to mature BDNF with high affinity, but not to other NTs. More interestingly, this interaction was enhanced at acidic pH compared with neutral pH. Thus, it is conceivable that stronger binding between BDNF and its pro-peptide may occur in acidic intracellular compartments such as trafficking vesicles, rather than in the extracellular space. To explore the physiological role of this interaction, we performed electrophysiological studies. Interestingly, when pre-incubated with BDNF, the BDNF pro-peptide completely attenuated the ability of BDNF to inhibit hippocampal LTD6. Thus, these results suggest that the BDNF pro-peptide, when co-released with BDNF, might modulate the availability of BDNF via a stable interaction in the extracellular space.

Recently, numerous reports have revealed the roles and functions of BDNF in the PNS and the brain-body interface. BDNF expression is up-regulated in models of neuropathic pain, and BDNF enhances the ventral root potential induced by C-fiber stimulation, demonstrating the mechanical role of BDNF in the development of neuropathic pain21. However, injury to the sural nerve, which almost innervates skin, does not induce neuropathic pain. Recently, Zhou et al. (2010) indicated that sural nerve injury fails to produce neuropathic pain due to a limited amount of BDNF contained in the nerve22. Furthermore, in another recent study, Liu et al. (2017) demonstrated that TNF-alpha differentially regulates synaptic plasticity in the hippocampus and spinal cord via microglia-dependent mechanisms after peripheral nerve injury23, suggesting a mechanical difference between chronic pain and memory deficit.

Exercise provides many beneficial effects to the human brain, including improving cognitive function, reducing the risk of Alzheimer’s disease, and alleviating depression24. Recently, Ogborn et al. (2010) showed that 5 days of treadmill exercise elevated BDNF expression in the soleus more than in the medial gastrocnemius25. More recently, it was demonstrated that up-regulation of BDNF expression in the hippocampus after exercise is mediated by activation of the important metabolic mediator, peroxisome proliferator-activated receptor γ (PPARγ) coactivator-1a (PGC-1a) and the previously identified muscle protein fibronectin type III domain containing 5 (FNDC5)26, suggesting that the regulation of BDNF expression linking the brain and body after exercise is distinct from the neuronal activity-dependent up-regulation of BDNF expression that enhances synaptic function in the brain.

These findings provide new insight into the development of neuropathic pain and brain-body connections after exercise. Since both the BDNF pro-peptide and BDNF are derived from the same precursor, exactly how the BDNF pro-peptide contributes to the PNS and brain-body connections remains to be determined in future studies.

This review article was supported by a Grant-in-Aid for Scientific Research on Priority Areas (elucidation of neural network function in the brain) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a KAKENHI Grant-in-Aid for Scientific Research (17K07073 and 22500305) (M.K.); the Japan Science and Technology Agency and Core Research for Evolutional Science and Technology (CREST) (T.M. and M.K).

  1. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000; 14: 2919-2937.
  2. Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003; 4: 299-309.
  3. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci. 2006; 361: 1545-1564.
  4. Waterhouse EG, Xu B. New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci. 2009; 42: 81-89.
  5. Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013; 14: 7-23.
  6. Mizui T, Ishikawa Y, Kumanogoh H, et al. BDNF pro-peptide actions facilitate hippocampal LTD and are altered by the common BDNF polymorphism Val66Met. Proc Natl Acad Sci U S A. 2015; 112: E3067-3074.
  7. Poo MM. Neurotrophins as synaptic modulators. Nat Rev Neurosci. 2001; 2: 24-32.
  8. Lessmann V, Brigadski T. Mechanisms, locations, and kinetics of synaptic BDNF secretion: an update. Neurosci Res. 2009; 65: 11-22.
  9. Seidah NG, Benjannet S, Pareek S, et al Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett. 1996; 379: 247-250.
  10. Mowla SJ, Pareek S, Farhadi HF, et al. Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J Neurosci. 1999; 19: 2069-2080.
  11. Leibrock J, Lottspeich F, Hohn A, et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 1989; 341: 149-152.
  12. Dieni S, Matsumoto T, Dekkers M, et al. BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons. J Cell Biol. 2012; 196: 775-788.
  13. Lessmann V, Gottmann K, Heumann R. BDNF and NT-4/5 enhance glutamatergic synaptic transmission in cultured hippocampal neurones. Neuroreport. 1994; 6: 21-25.
  14. Figurov A, Pozzo-Miller LD, Olafsson P, et al. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature. 1996; 381: 706-709.
  15. Patterson SL, Abel T, Deuel TA, et al. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron. 1996; 16: 1137-1145.
  16. Xu B, Gottschalk W, Chow A, et al. The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J Neurosci. 2000; 20: 6888-6897.
  17. Minichiello L, Calella AM, Medina DL, et al. Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron. 2002; 36: 121-137.
  18. Kolbeck R, Jungbluth S, Barde YA. Characterisation of neurotrophin dimers and monomers. Eur J Biochem. 1994; 225: 995-1003.
  19. Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003; 112: 257-269.
  20. Uegaki K, Kumanogoh H, Mizui T, et al. BDNF Binds Its Pro-Peptide with High Affinity and the Common Val66Met Polymorphism Attenuates the Interaction. International journal of molecular sciences. 2017; 18: 1042-1031.
  21. Pezet S, Malcangio M, McMahon SB. BDNF: a neuromodulator in nociceptive pathways? Brain research. Brain research reviews. 2002; 40: 240-249.
  22. Zhou LJ, Ren WJ, Zhong Y, et al. Limited BDNF contributes to the failure of injury to skin afferents to produce a neuropathic pain condition. Pain. 2010; 148: 148-157.
  23. Liu Y, Zhou LJ, Wang J, et al. TNF-alpha Differentially Regulates Synaptic Plasticity in the Hippocampus and Spinal Cord by Microglia-Dependent Mechanisms after Peripheral Nerve Injury. J Neurosci. 2017; 37: 871-881.
  24. Mattson MP. Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell metabolism. 2012; 16: 706-722.
  25. Ogborn DI, Gardiner PF. Effects of exercise and muscle type on BDNF, NT-4/5, and TrKB expression in skeletal muscle. Muscle & nerve. 2010; 41: 385-391.
  26. Wrann CD, White JP, Salogiannnis J, et al. Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway. Cell metabolism. 2013; 18: 649-659.

Article Info

Article Notes

  • Published on: November 24, 2018


  • Growth factor

  • BDNF
  • pro-peptide
  • pro-domain
  • synaptic plasticity
  • CNS
  • PNS
  • LTP
  • LTD


Dr. Toshiyuki Mizui
Biomedical Research Inst. (BMD), National Institute of Advanced Industrial Science and Technology (AIST), 1-8-31 Midorioka, Ikeda, Osaka, 563-8577, Japan